Harnessing The Role Of Rubiadin in Cancer: Current Scenario And Future Perspectives

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Oncology

Background:

• Cancer is a leading global cause of mortality, necessitating novel therapeutic strategies.
• Conventional chemotherapy poses risks of recurrence and adverse effects, driving interest in natural compounds.
• Anthraquinones represent a promising class of compounds with potential anticancer properties.

Purpose of the Study:

• To provide a comprehensive review of rubiadin, an anthraquinone with anticancer potential.
• To explore rubiadin's natural sources, synthetic pathways, chemical structure, and analogues.
• To elucidate the molecular mechanisms and pharmacokinetics of rubiadin's anticancer effects.

Main Methods:

• Systematic review of existing literature on rubiadin.
• Analysis of natural sources and synthetic routes for rubiadin production.
• Summary of pre-clinical studies investigating rubiadin's efficacy and mechanisms.

Main Results:

• Rubiadin is an anthraquinone found in natural and synthetic forms with diverse applications.
• Detailed insights into rubiadin's chemical structure, analogues, and synthesis are presented.
• Pre-clinical data suggest rubiadin possesses anticancer properties and specific molecular mechanisms.

Conclusions:

• Rubiadin demonstrates multifaceted potential as a natural anticancer agent.
• The review highlights the need for continued research and development of rubiadin.
• Rubiadin offers a promising alternative or adjunct to conventional cancer therapies.